SYS-CON MEDIA Authors: Kevin Benedict, Gilad Parann-Nissany, Unitiv Blog, RealWire News Distribution, Jason Bloomberg

News Feed Item

Keynote Address at 10th Annual European PRO & eCOA Congress to Highlight the Site Experience in Adopting eClinical Technologies for Patient-Centric Research

The world’s pharmaceutical pacesetters will share lessons learned, best practices and trends in leveraging patient reported outcome (PRO) and electronic clinical outcome assessment (eCOA) Systems for better clinical research at the premier educational PRO & eCOA Congress, 3-5 June in Barcelona. The meeting is hosted by PHT Corporation, the leading provider of technologies used to collect patient-driven eData for clinical research.

Register here: bit.ly/CongressBarcelona. Join the PRO & eCOA Congress LinkedIn Community.

Vivienne van de Walle, MD, PhD, CPI, Medical Director, Owner and Research Physician, PreCare Trial & Recruitment (PT&R), will keynote the Congress with a presentation entitled “The Site Experience: Patient-Centricity & eCOA at the Clinical Site.”

Dr. van de Walle is an expert at integrating patient care and clinical research. She studied medicine at the University of Maastricht and the University of Oxford, and received an additional medical science degree for her research in OB-GYN, pediatrics and genetics. She has been a full time investigator since 1999. Dr. van de Walle is a member of the BROK/GCP exam cie, ACRON, APCR and NVFG. She has taught and consulted with CROs, pharmaceutical companies and universities on protocol development, feasibilities, the sponsor-site relationship, and social media.

Sheila Rocchio, MBA, PHT Vice President of Marketing and Product Management, said, “The PRO & eCOA Congress brings together leading pharmaceutical, science and regulatory innovators to advance the adoption of eCOA technologies for patient-centric clinical research. This is the event for sponsors looking to understand the science of patient-driven outcomes and the benefit and differentiation these data streams can provide in clinical programs.” Learn more about the PRO & eCOA Congress in one minute: http://bit.ly/1h39AHS

Other confirmed presentations from pharmaceutical innovators at Novo Nordisk, F. Hoffmann-La Roche, Celgene and more include:

  • eCOA Case Study: Lessons Learned Collecting ePRO in a Metastatic Breast Cancer Study
  • ePRO: How to Get to DBL and Beyond
  • Measurement Equivalence of the SF-36 on a Handheld Device and Smartphone App
  • The Paper to ePRO Transition: Determining the Right Collection Period
  • Patient Recruitment & Retention
  • Case Study: Increasing Study Efficiencies with an eCOA Library

Additional workshops, panel discussions, case studies and presentations by industry and PHT speakers will cover pros and cons for “Bring Your Own Device” models for ePRO; patient-centric clinical research; developing instruments for eCOA; objective measures of patient benefit; and, eCOA use within pediatric trials. The complete agenda is available online.

About PHT Corporation

PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT electronic clinical outcome assessment (eCOA) Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via StudyWorks™ online reporting portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 660+ global trials resulting in 16+ regulatory approvals. PHT Clinical Science and Consulting offers the scientific, regulatory, and technological expertise today’s eCOA market demands and patients deserve. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.